Rapid Dose Therapeutics (XCNQ:DOSE) 3-Year EBITDA Growth Rate : 33.90% (As of Nov. 2023)

View and export this data going back to 2010. Start your Free Trial

What is Rapid Dose Therapeutics 3-Year EBITDA Growth Rate?

Rapid Dose Therapeutics's EBITDA per Share for the three months ended in Nov. 2023 was C$-0.01.

During the past 3 years, the average EBITDA Per Share Growth Rate was 33.90% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 32.90% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 11.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Rapid Dose Therapeutics was 58.50% per year. The lowest was -193.20% per year. And the median was 18.40% per year.

Competitive Comparison of Rapid Dose Therapeutics's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Rapid Dose Therapeutics's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rapid Dose Therapeutics's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Rapid Dose Therapeutics's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Rapid Dose Therapeutics's 3-Year EBITDA Growth Rate falls into.

Rapid Dose Therapeutics 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Rapid Dose Therapeutics (XCNQ:DOSE) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Rapid Dose Therapeutics 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Rapid Dose Therapeutics's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Rapid Dose Therapeutics (XCNQ:DOSE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rapid Dose Therapeutics Corp (XCNQ:DOSE) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

RDTCF:USA

Address

1121 Walkers Line, Unit 3, Burlington, ON, CAN, L7N 2G4

Website

http://www.rapid-dose.com

Rapid Dose Therapeutics Corp is a Canadian biotechnology company revolutionizing drug delivery through innovation. The company's flagship product QuickStrip is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients (nutraceuticals, pharmaceuticals, vaccines, cannabis) that are delivered quickly into the bloodstream resulting in rapid onset of the active ingredient.

Rapid Dose Therapeutics (XCNQ:DOSE) Headlines

No Headlines